VanEck Associates’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Sell |
11,336
-3,784
| -25% | -$993K | ﹤0.01% | 893 |
|
|
2025
Q1 | $3.52M | Buy |
15,120
+2,001
| +15% | +$466K | ﹤0.01% | 839 |
|
|
2024
Q4 | $3.01M | Sell |
13,119
-749
| -5% | -$172K | ﹤0.01% | 868 |
|
|
2024
Q3 | $3.05M | Buy |
13,868
+694
| +5% | +$153K | ﹤0.01% | 813 |
|
|
2024
Q2 | $2.68M | Buy |
13,174
+11,869
| +910% | +$2.42M | ﹤0.01% | 791 |
|
|
2024
Q1 | $285K | Buy |
1,305
+51
| +4% | +$11.1K | ﹤0.01% | 1129 |
|
|
2023
Q4 | $285K | Sell |
1,254
-5,550
| -82% | -$1.26M | ﹤0.01% | 1121 |
|
|
2023
Q3 | $1.37M | Sell |
6,804
-2,848
| -30% | -$573K | ﹤0.01% | 816 |
|
|
2023
Q2 | $2M | Buy |
9,652
+3,485
| +57% | +$722K | ﹤0.01% | 729 |
|
|
2023
Q1 | $1.22M | Buy |
6,167
+57
| +0.9% | +$11.2K | ﹤0.01% | 790 |
|
|
2022
Q4 | $1.24M | Sell |
6,110
-11,205
| -65% | -$2.27M | ﹤0.01% | 761 |
|
|
2022
Q3 | $3.05M | Buy |
17,315
+837
| +5% | +$147K | 0.01% | 557 |
|
|
2022
Q2 | $3.32M | Sell |
16,478
-1,526
| -8% | -$307K | 0.01% | 556 |
|
|
2022
Q1 | $4.08M | Buy |
18,004
+2,060
| +13% | +$467K | 0.01% | 549 |
|
|
2021
Q4 | $4.3M | Buy |
15,944
+11,699
| +276% | +$3.16M | 0.01% | 538 |
|
|
2021
Q3 | $1.03M | Buy |
4,245
+871
| +26% | +$211K | ﹤0.01% | 804 |
|
|
2021
Q2 | $800K | Buy |
3,374
+227
| +7% | +$53.8K | ﹤0.01% | 838 |
|
|
2021
Q1 | $690K | Buy |
+3,147
| New | +$690K | ﹤0.01% | 801 |
|